Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

dc.contributor.author	Humbert, M.
dc.contributor.author	Beasley, R.
dc.contributor.author	Ayres, J.
dc.contributor.author	Slavin, R.
dc.contributor.author	Hebert, J.
dc.contributor.author	Bousquet, J.
dc.contributor.author	Beeh, K. M.
dc.contributor.author	Ramos González, Sofía María del Carmen
dc.contributor.author	Canonica, G. W.
dc.contributor.author	Hedgecock, S.
dc.contributor.author	Fox, H.
dc.contributor.author	Blogg, M.
dc.contributor.author	Surrey, K.
dc.date.accessioned	2014-03-14T07:40:52Z
dc.date.available	2014-03-14T07:40:52Z
dc.date.issued	2005
dc.identifier.citation	ALLERGY, 60(3), p. 309-316 (2005); doi:10.1111/j.1398-9995.2004.00772.x
dc.identifier.issn	0105-4538
dc.identifier.uri	http://hdl.handle.net/10651/23693
dc.format.extent	p. 309-316
dc.language.iso	eng
dc.relation.ispartof	ALLERGY
dc.rights	© Blackwell Munksgaard 2004
dc.source	WOS
dc.title	Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
dc.type	journal article
dc.identifier.local	20140589
dc.identifier.doi	10.1111/j.1398-9995.2004.00772.x
dc.relation.publisherversion	http://dx.doi.org/10.1111/j.1398-9995.2004.00772.x

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.